BioSig Technologies, Inc. (NASDAQ:BSGM) said it has entered into an evaluation agreement for its PURE EP System with Cleveland Clinic, its first following the induction of a new commercialization team to accelerate the process from product evaluation to adoption.
The medical technology company said Cleveland Clinic, a non-profit multi-specialty academic medical center, will participate in a 60-day evaluation of BioSig's signal processing platform.
"We are excited to include Cleveland Clinic as an evaluation center for the Pure EP System,” said Gray Fleming, BioSig's chief commercialization officer, in a statement. “We look forward to working alongside their physicians to demonstrate the superior signal quality that can be achieved on even the most difficult arrhythmias.”
READ: BioSig Technologies looking to unlock the future of bioelectronic medicine
BioSig said to date, more than 75 physicians have completed over 2,500 patient cases with the PURE EP System, which is being commercially launched nationwide. The technology is in regular use in some of the country's leading centers of excellence, including Mayo Clinic, and the Texas Cardiac Arrhythmia Institute at St. David's Medical Center.
Clinical data acquired by the PURE EP System in a multi-center study at centers of excellence, including at the Texas Cardiac Arrhythmia Institute, showed 93% consensus across blinded reviewers with a 75% overall improvement in intracardiac signal quality and confidence in interpreting PURE EP signals over conventional sources, BioSig said.
BioSig is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals.
Contact the author at jon.hopkins@proactiveinvestors.com
"pure" - Google News
June 22, 2022 at 08:15PM
https://ift.tt/8RcQKI1
BioSig Technologies enters deal for Cleveland Clinic to evaluate its PURE EP signal processing platform - Proactive Investors USA
"pure" - Google News
https://ift.tt/EFBbQ8r
https://ift.tt/1dXNDxL
Bagikan Berita Ini
0 Response to "BioSig Technologies enters deal for Cleveland Clinic to evaluate its PURE EP signal processing platform - Proactive Investors USA"
Post a Comment